Literature DB >> 25377562

Cryptic XPO1-MLLT10 translocation is associated with HOXA locus deregulation in T-ALL.

Jonathan Bond1, Aurélie Bergon2, Amandine Durand1, Isabelle Tigaud3, Xavier Thomas4, Vahid Asnafi1, Salvatore Spicuglia5, Elizabeth Macintyre6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25377562      PMCID： PMC4224197          DOI： 10.1182/blood-2014-04-567636

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  10 in total

1.  Potent inhibition of DOT1L as treatment of MLL-fusion leukemia.

Authors:  Scott R Daigle; Edward J Olhava; Carly A Therkelsen; Aravind Basavapathruni; Lei Jin; P Ann Boriack-Sjodin; Christina J Allain; Christine R Klaus; Alejandra Raimondi; Margaret Porter Scott; Nigel J Waters; Richard Chesworth; Mikel P Moyer; Robert A Copeland; Victoria M Richon; Roy M Pollock
Journal:  Blood       Date:  2013-06-25       Impact factor: 22.113

2.  CALM-AF10 is a common fusion transcript in T-ALL and is specific to the TCRgammadelta lineage.

Authors:  Vahid Asnafi; Isabelle Radford-Weiss; Nicole Dastugue; Chantal Bayle; Daniel Leboeuf; Christiane Charrin; Richard Garand; Marina Lafage-Pochitaloff; Eric Delabesse; Agnes Buzyn; Xavier Troussard; Elizabeth Macintyre
Journal:  Blood       Date:  2003-04-03       Impact factor: 22.113

3.  HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL).

Authors:  Jean Soulier; Emmanuelle Clappier; Jean-Michel Cayuela; Armelle Regnault; Marina García-Peydró; Hervé Dombret; André Baruchel; Maria-Luisa Toribio; François Sigaux
Journal:  Blood       Date:  2005-03-17       Impact factor: 22.113

4.  The prognosis of CALM-AF10-positive adult T-cell acute lymphoblastic leukemias depends on the stage of maturation arrest.

Authors:  Raouf Ben Abdelali; Vahid Asnafi; Arnaud Petit; Jean-Baptiste Micol; Céline Callens; Patrick Villarese; Eric Delabesse; Oumedaly Reman; Stephane Lepretre; Jean-Yves Cahn; Gaelle Guillerm; Céline Berthon; Claude Gardin; Bernadette Corront; Thibaut Leguay; Marie-Christine Béné; Norbert Ifrah; Guy Leverger; Hervé Dombret; Elizabeth Macintyre
Journal:  Haematologica       Date:  2013-07-05       Impact factor: 9.941

5.  The recurrent SET-NUP214 fusion as a new HOXA activation mechanism in pediatric T-cell acute lymphoblastic leukemia.

Authors:  Pieter Van Vlierberghe; Martine van Grotel; Joëlle Tchinda; Charles Lee; H Berna Beverloo; Peter J van der Spek; Andrew Stubbs; Jan Cools; Kyosuke Nagata; Maarten Fornerod; Jessica Buijs-Gladdines; Martin Horstmann; Elisabeth R van Wering; Jean Soulier; Rob Pieters; Jules P P Meijerink
Journal:  Blood       Date:  2008-02-25       Impact factor: 22.113

6.  New MLLT10 gene recombinations in pediatric T-acute lymphoblastic leukemia.

Authors:  Lucia Brandimarte; Valentina Pierini; Danika Di Giacomo; Chiara Borga; Filomena Nozza; Paolo Gorello; Marco Giordan; Giovanni Cazzaniga; Geertruy Te Kronnie; Roberta La Starza; Cristina Mecucci
Journal:  Blood       Date:  2013-05-14       Impact factor: 22.113

7.  KPT-330 inhibitor of CRM1 (XPO1)-mediated nuclear export has selective anti-leukaemic activity in preclinical models of T-cell acute lymphoblastic leukaemia and acute myeloid leukaemia.

Authors:  Julia Etchin; Takaomi Sanda; Marc R Mansour; Alex Kentsis; Joan Montero; Bonnie T Le; Amanda L Christie; Dilara McCauley; Scott J Rodig; Michael Kauffman; Sharon Shacham; Richard Stone; Anthony Letai; Andrew L Kung; A Thomas Look
Journal:  Br J Haematol       Date:  2013-02-04       Impact factor: 6.998

8.  Analysis of TCR, pT alpha, and RAG-1 in T-acute lymphoblastic leukemias improves understanding of early human T-lymphoid lineage commitment.

Authors:  Vahid Asnafi; Kheira Beldjord; Emmanuelle Boulanger; Béatrice Comba; Patricia Le Tutour; Marie-Hélène Estienne; Frédéric Davi; Judith Landman-Parker; Pierre Quartier; Agnès Buzyn; Eric Delabesse; Françoise Valensi; Elizabeth Macintyre
Journal:  Blood       Date:  2002-11-21       Impact factor: 22.113

9.  The MLL recombinome of acute leukemias in 2013.

Authors:  C Meyer; J Hofmann; T Burmeister; D Gröger; T S Park; M Emerenciano; M Pombo de Oliveira; A Renneville; P Villarese; E Macintyre; H Cavé; E Clappier; K Mass-Malo; J Zuna; J Trka; E De Braekeleer; M De Braekeleer; S H Oh; G Tsaur; L Fechina; V H J van der Velden; J J M van Dongen; E Delabesse; R Binato; M L M Silva; A Kustanovich; O Aleinikova; M H Harris; T Lund-Aho; V Juvonen; O Heidenreich; J Vormoor; W W L Choi; M Jarosova; A Kolenova; C Bueno; P Menendez; S Wehner; C Eckert; P Talmant; S Tondeur; E Lippert; E Launay; C Henry; P Ballerini; H Lapillone; M B Callanan; J M Cayuela; C Herbaux; G Cazzaniga; P M Kakadiya; S Bohlander; M Ahlmann; J R Choi; P Gameiro; D S Lee; J Krauter; P Cornillet-Lefebvre; G Te Kronnie; B W Schäfer; S Kubetzko; C N Alonso; U zur Stadt; R Sutton; N C Venn; S Izraeli; L Trakhtenbrot; H O Madsen; P Archer; J Hancock; N Cerveira; M R Teixeira; L Lo Nigro; A Möricke; M Stanulla; M Schrappe; L Sedék; T Szczepański; C M Zwaan; E A Coenen; M M van den Heuvel-Eibrink; S Strehl; M Dworzak; R Panzer-Grümayer; T Dingermann; T Klingebiel; R Marschalek
Journal:  Leukemia       Date:  2013-04-30       Impact factor: 11.528

10.  Preclinical and clinical efficacy of XPO1/CRM1 inhibition by the karyopherin inhibitor KPT-330 in Ph+ leukemias.

Authors:  Christopher J Walker; Joshua J Oaks; Ramasamy Santhanam; Paolo Neviani; Jason G Harb; Gregory Ferenchak; Justin J Ellis; Yosef Landesman; Ann-Kathrin Eisfeld; Nash Y Gabrail; Carrie L Smith; Michael A Caligiuri; Peter Hokland; Denis Claude Roy; Alistair Reid; Dragana Milojkovic; John M Goldman; Jane Apperley; Ramiro Garzon; Guido Marcucci; Sharon Shacham; Michael G Kauffman; Danilo Perrotti
Journal:  Blood       Date:  2013-08-22       Impact factor: 22.113
  10 in total
  9 in total

1.  HOXA-activated early T-cell progenitor acute lymphoblastic leukemia: predictor of poor outcome?

Authors:  Jules Pp Meijerink; Kirsten Canté-Barrett; Eric Vroegindeweij; Rob Pieters
Journal:  Haematologica       Date:  2016-06       Impact factor: 9.941

2.  Detection and prognostic value of recurrent exportin 1 mutations in tumor and cell-free circulating DNA of patients with classical Hodgkin lymphoma.

Authors:  Vincent Camus; Aspasia Stamatoullas; Sylvain Mareschal; Pierre-Julien Viailly; Nasrin Sarafan-Vasseur; Elodie Bohers; Sydney Dubois; Jean Michel Picquenot; Philippe Ruminy; Catherine Maingonnat; Philippe Bertrand; Marie Cornic; Valérie Tallon-Simon; Stéphanie Becker; Liana Veresezan; Thierry Frebourg; Pierre Vera; Christian Bastard; Hervé Tilly; Fabrice Jardin
Journal:  Haematologica       Date:  2016-06-13       Impact factor: 9.941

3.  An early thymic precursor phenotype predicts outcome exclusively in HOXA-overexpressing adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study.

Authors:  Jonathan Bond; Tony Marchand; Aurore Touzart; Agata Cieslak; Amélie Trinquand; Laurent Sutton; Isabelle Radford-Weiss; Ludovic Lhermitte; Salvatore Spicuglia; Hervé Dombret; Elizabeth Macintyre; Norbert Ifrah; Jean-François Hamel; Vahid Asnafi
Journal:  Haematologica       Date:  2016-03-04       Impact factor: 9.941

Review 4.  XPO1 in B cell hematological malignancies: from recurrent somatic mutations to targeted therapy.

Authors:  Vincent Camus; Hadjer Miloudi; Antoine Taly; Brigitte Sola; Fabrice Jardin
Journal:  J Hematol Oncol       Date:  2017-02-14       Impact factor: 17.388

5.  Genetic variants and increased risk of meningioma: an updated meta-analysis.

Authors:  Xiao-Yong Han; Wei Wang; Lei-Lei Wang; Xi-Rui Wang; Gang Li
Journal:  Onco Targets Ther       Date:  2017-03-28       Impact factor: 4.147

6.  Heterozygous mutation of cysteine528 in XPO1 is sufficient for resistance to selective inhibitors of nuclear export.

Authors:  Jasper Edgar Neggers; Els Vanstreels; Erkan Baloglu; Sharon Shacham; Yosef Landesman; Dirk Daelemans
Journal:  Oncotarget       Date:  2016-10-18

Review 7.  Targeting nuclear import and export in hematological malignancies.

Authors:  Boaz Nachmias; Aaron D Schimmer
Journal:  Leukemia       Date:  2020-07-05       Impact factor: 11.528

8.  Clinico-biological features of T-cell acute lymphoblastic leukemia with fusion proteins.

Authors:  Thomas Steimlé; Marie-Emilie Dourthe; Marion Alcantara; Aurore Touzart; Mathieu Simonin; Johanna Mondesir; Ludovic Lhermitte; Jonathan Bond; Carlos Graux; Nathalie Grardel; Jean-Michel Cayuela; Isabelle Arnoux; Virginie Gandemer; Marie Balsat; Norbert Vey; Elizabeth Macintyre; Norbert Ifrah; Hervé Dombret; Arnaud Petit; André Baruchel; Philippe Ruminy; Nicolas Boissel; Vahid Asnafi
Journal:  Blood Cancer J       Date:  2022-01-26       Impact factor: 9.812

9.  The role of the PZP domain of AF10 in acute leukemia driven by AF10 translocations.

Authors:  Brianna J Klein; Anagha Deshpande; Khan L Cox; Fan Xuan; Mohamad Zandian; Karina Barbosa; Sujita Khanal; Qiong Tong; Yi Zhang; Pan Zhang; Amit Sinha; Stefan K Bohlander; Xiaobing Shi; Hong Wen; Michael G Poirier; Aniruddha J Deshpande; Tatiana G Kutateladze
Journal:  Nat Commun       Date:  2021-07-05       Impact factor: 14.919
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.